On Monday, the Dow and S&P posted record highs while the NASDAQ crossed the 5,000 mark for the first time in 15 years.
On Friday, S&P Dow Jones Indices said Apple (AAPL.O), the largest U.S. firm by market value, will replace AT&T (T.N) in its Dow index on March 18.
Insights about U.S. Stocks that landed in the Active-Zone during Friday’s trade, are depicted underneath:
Twenty-First Century Fox Inc (NASDAQ:FOXA)’s shares dipped-1.08%, and traded at $34.49. The Stock is active as 10.69M shares changed hands versus its average volume of 14.52M shares.
Twenty-First Century Fox, Inc. (FOXA)’s partner FOX News Channel (FNC), has hired minister and civil rights activist Dr. Alveda King as a contributor, declared Roger Ailes, Chairman and CEO, FOX News. In this role, Dr. King will provide social and cultural commentary across FNC’s daytime and primetime programming.
In making the declaration, Ailes said, “Alveda has brilliantly carried the legacy of the King family to the next generation and has been a source of inspiration for many Americans. Her passion and mission for social change will be a valuable contribution to our network.”
The founder of Alveda King Ministries, Dr. King presently serves as Director of African-American Outreach at Priests for Life. She is the daughter of the late civil rights activist Rev. A. D. King and wife Naomi Barber King in addition to the niece of civil rights leader Dr. Martin Luther King Jr. She has continued her family’s long line of advocacy work by speaking out on issues that face society recently. Dr. King is a Senior Fellow with the Howard Center for Family and is also a member of several organizations counting, the National Black Pro-Life Coalition (NBPC), the Coalition of African American Pastors and the Judeo-Christian Coalition for Constitutional Restoration.
FOX News Channel (FNC) is a 24-hour all-encompassing news service dedicated to delivering breaking news in addition to political and business news.
Twenty-First Century Fox, Inc. operates as a diversified media and entertainment corporation worldwide. It operates through Cable Network Programming, Television, Filmed Entertainment, and Direct Broadcast Satellite Television segments.
Boston Scientific Corporation (NYSE:BSX), declined -2.42%, and traded at $16.56. The Stock is active as 10.11M shares changed hands versus its average volume of 14.18M shares.
Boston Scientific Company, (BSX), declares the election of Charles J. Dockendorff and Stephen P. MacMillan to its board of directors, effective April 1, 2015. Two current members of the board, Uwe E. Reinhardt and Bruce L. Byrnes, will not stand for re-election at the corporation’s annual meeting of stockholders in May 2015. Charles J. Dockendorff was formerly the executive vice president and chief financial officer of Covidien plc. Mr. Dockendorff presently serves on the board of directors of Haemonetics Corporation and Keysight Technologies. He received his B.A. in Business Administration and Accounting from the University of Massachusetts at Amherst and received his Master of Science in Finance from Bentley College.
Stephen P. MacMillan is presently the president and chief executive officer of Hologic, a leading global healthcare and diagnostics corporation. Formerly, Mr. MacMillan served as president and chief executive officer of Stryker Corporation. He presently serves on the board of directors of Alere Inc. Mr. MacMillan received a Bachelor of Arts degree in Economics from Davidson College and is a graduate of Harvard Business School’s Advanced Administration Program.
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
MannKind Corporation (NASDAQ:MNKD), dropped -4.54%, and traded at $5.47. The Stock is active as 9.83M shares changed hands versus its average volume of 7.35M shares. The company holds the book value per share of -0.19, whereas cash per share is 0.30. Analysts mean recommendation for the stock is said to be 2.60 (where 1=Buy, 5=sale).
MannKind Corporation, a biopharmaceutical corporation, focuses on the discovery, development, and commercialization of therapeutic products for diabetes in the United States.
Chimera Investment Corporation (NYSE:CIM), dwindled -1.88%, and traded at $3.13. The Stock is active as 9.73M shares changed hands versus its average volume of 3.65M shares.
Chimera Investment Corporation (CIM), declared its financial results for the yearend and fourth quarter 2014 as follows:
2014 Annual Financial Highlights:
- Average earning assets grew to $10.0 billion from $5.8 billion in 2013 based on amortized cost
- Net Revenue of $589 million as contrast to $363 million in 2013
- GAAP book value of $3.51 per share, an raise of 8% from 2013
- Economic book value of $3.18 per share, an raise of 13% from 2013
- Annual return on average equity was 17%, up from 11% in 2013
- Core earnings of $0.39 per share, up from $0.34 per share for 2013
4th Quarter 2014 Financial Highlights:
- GAAP book value of $3.51 per share, from $3.50 per share for the 3rd quarter of 2014
- Economic book value of $3.18 per share, up from $3.15 per share for the 3rd quarter of 2014
- Core earnings of $0.12 per share, up from $0.11 per share in the 3rd quarter of 2014
- Net interest revenue of $177 million, up from $151 million in the 3rd quarter of 2014
The Corporation stated GAAP net revenue for the quarter ended December 31, 2014 of $6 million or $0.01 per average share as contrast to net revenue for the quarter ended December 31, 2013 of $72 million or $0.07 per average share.
The Corporation declared a ordinary stock dividend of $0.09 per share for the quarter ended December 31, 2014. The annualized dividend yield on the Corporation’s ordinary stock for the quarter ended December 31, 2014 was 11%.
Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The corporation, through its auxiliaries, invests in residential mortgage-backed securities (RMBS), residential mortgage loans, commercial mortgage loans, real estate-related securities, and various other asset classes. Its targeted asset classes comprise non-agency RMBS, such as investment-grade and non-investment grade classes; agency RMBS; insured loans; and first or second lien loans secured by multifamily properties, mixed residential or other commercial properties, retail properties, office properties, and industrial properties.
